NCT04002492

Brief Summary

Low bone density is a health risk in older adults and especially people with multiple sclerosis (MS) due to steroid treatments and less mobility. Bone density is a measurement of how dense or strong bones are. Weight-based training may be one method in strengthening bones and providing a beneficial treatment for MS patient rehabilitation. Weight based training involves performing exercises without the use of actual weights, and instead with one's own bodyweight. This study aims to look at the effects of weight-based training on bone density, cognition (ability to learn and understand), and other quality of life issues (i.e. depression) in MS patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 28, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 15, 2019

Status Verified

August 1, 2019

Enrollment Period

4 months

First QC Date

June 14, 2019

Last Update Submit

August 13, 2019

Conditions

Keywords

sarcopeniaosteopeniaexercisebody weight trainingbone densitydemyelinationcognition

Outcome Measures

Primary Outcomes (1)

  • Osteopenia

    Change in bone density due to the addition of two body weight training sessions per week for a six (to eight) week time period. Bone density will be measured via a DEXA bone density scan at day one of the trial and a secondary DEXA scan taking place eight weeks after the final training session. The duration of this aspect of the study falls between 14 and 16 weeks depending on participant training schedule and if rescheduled or make up training sessions are needed.

    14 to 16 weeks

Secondary Outcomes (2)

  • Depression and Quality of Life: MSIS (Multiple Sclerosis impact scale) survey/questionnaire

    14 to 16 weeks

  • Cognition

    14 to 16 weeks

Study Arms (1)

Addition of bodyweight training

EXPERIMENTAL

All participants in this study fall into this non randomized single group. These participants will complete a total of 12 bodyweight training sessions over a six to eight week time period. Participants will attend one session per week at Holy Name Medical Center's Physical Therapy Center and will train for one session at their home or chosen location with the aid of a video guide.

Behavioral: Bodyweight training

Interventions

Video guided and physical therapist guided bodyweight training sessions will be performed twice a week for 6 (to 8) weeks. These sessions include the following five workouts at 3 sets of 10 repetitions: step ups, calf raises, wall push ups, chair squats, and chair dips.

Addition of bodyweight training

Eligibility Criteria

Age40 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local subject privacy regulations.
  • Diagnosis of RRMS, PPMS, SPMS, or CIS per the 2010 McDonald's criteria \[Polman 2011\].
  • Baseline EDSS score less than 5.5

You may not qualify if:

  • Unable or unwilling to provide informed consent.
  • Inability to read or understand English.
  • Any contraindication to perform weight-based training exercises.
  • Use of any supplemental human growth hormone, performance enhancing drug, or anabolic (non-clinical) steroid.
  • Participant has become or intends on becoming pregnant.
  • Participant has had a relapse in the past 6 months.
  • Patients who currently exercise more than three times per week.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Holy Name Medical Center

Teaneck, New Jersey, 07666, United States

Location

MeSH Terms

Conditions

Multiple SclerosisSarcopeniaBone Diseases, MetabolicMotor ActivityDemyelinating Diseases

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesAutoimmune DiseasesImmune System DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Study Officials

  • Mary Ann Picone

    Holy Name Medical Center Multiple Sclerosis Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director of Holy Name Comprehensive Care Center

Study Record Dates

First Submitted

June 14, 2019

First Posted

June 28, 2019

Study Start

July 1, 2019

Primary Completion

November 1, 2019

Study Completion

December 1, 2019

Last Updated

August 15, 2019

Record last verified: 2019-08

Locations